FIRE3_2A: FIRE3, figure 2A

FIRE3_2AR Documentation

FIRE3, figure 2A

Description

Kaplan-Meier digitized data from FIRE3, figure 2A (PMID 25088940). A reported sample size of 592 for a primary endpoint of objective_response in colorectal cancer.

Usage

FIRE3_2A

Format

A data frame of 592 observations and 3 variables:

time event time (in months)
event PFS event indicator (0: no event, 1: event)
arm treatment arms (folfiri_bevacizumab, folfiri_cetuximab)

Source

Heinemann V, von Weikersthal LF, Decker T, et al. FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial. Lancet Oncol 2014; 15: 1065–75.

Examples

summary(FIRE3_2A)

kmplot(FIRE3_2A)

raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.